Novavax Inc
NVAX
Detailliertes Diagramm anzeigen
7.440USD
+0.330+4.64%
Handelsschluss 11/11, 16:00（ET）Kurse um 15 Minuten verzögert
1.21BMarktkapitalisierung
3.54KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+4.64%
5 Tage
-0.93%
1 Monat
-10.68%
6 Monate
+24.52%
Seit Jahresbeginn
-7.46%
1 Jahr
-17.43%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Novavax Inc
Währung: USD Aktualisiert: 2025-11-11Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ stabil. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Halten bewertet. Trotz einer sehr schwachen Marktentwicklung zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Novavax Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
9
Analysten
Halten
Aktuelles Rating
13.625
Kursziel
+91.63%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Novavax Inc Highlights
HöhepunkteRisiko
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=3.55)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=95.10M, string=6.75%)
institutional_hold%!(EXTRA string=Philippe Laffont)
institutional_hold_desc%!(EXTRA string=Philippe Laffont, string=3.84M)
activity_increase
activity_increase_desc%!(EXTRA string=0.03)
Novavax Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Novavax Inc Informationen
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
BörsenkürzelNVAX
UnternehmenNovavax Inc
CEOMr. John C. Jacobs
Websitehttps://www.novavax.com/?locale=US
Verwandte Finanzinstrumente
+2.27%
+2.88%
+2.95%
+1.84%
+2.59%
+4.84%
+4.57%
+6.99%
+3.73%
+4.59%
+2.03%
+1.90%
-0.34%
+3.09%
+2.22%
+2.93%
0.00%
+3.03%
+2.32%
+2.28%Beliebte Symbole
